ANP Ann: ATL1102 tox study to support clinical program in the US - 14th Nov 2022, 9:23am

annb0t

annb0t

Top 20
ANP Ann: ATL1102 tox study to support clinical program in the US
Price Sensitive: Y
Date: 14th Nov 2022, 9:23am

>>> Read announcement: Google: ANP Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ANP Ann: Publication of final Long COVID data for ATL1102 - 28th Sep 2023, 8:22am
Replies
0
Views
65
annb0t
annb0t
annb0t
ANP Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy - 26th Sep 2023, 9:12am
Replies
0
Views
83
annb0t
annb0t
annb0t
ANP Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK - 27th Jun 2023, 3:46pm
Replies
0
Views
94
annb0t
annb0t
annb0t
ANP Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial - 8th Jun 2023, 8:38am
Replies
0
Views
106
annb0t
annb0t
annb0t
ANP Ann: Dosing commenced in the ATL1102 toxicology study - 14th Mar 2023, 9:01am
Replies
0
Views
138
annb0t
annb0t
Top Bottom